25486056|t|Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease.
25486056|a|YKL-40, a pleotropic cytokine, is emerging as a risk factor and a prognostic predictor of atherosclerotic cardiovascular disease. We attempted to elucidate the genetic, clinical and biochemical correlates of circulating YKL-40 level and, by combining it with CHI3L1 gene variants, with the risk and long-term mortality of peripheral artery disease (PAD). Plasma YKL-40 concentrations were measured in 612 Taiwanese individuals who had no clinically overt systemic disease. Clinical parameters, CHI3L1 gene promoter variants and 18 biomarker levels were analyzed. Eighty-six PAD patients were further enrolled for analysis. Significant associations were found between CHI3L1 genotypes/haplotypes and YKL-40 levels for the health examination subjects (smallest p = 8.36 x 10-7 for rs4950928 and smallest p = 1.72 x 10-10 for haplotype TGG) and also for PAD patients. For the health examination subjects, circulating YKL-40 level, but not CHI3L1 gene variants, were positively associated with age, smoking, and circulating levels of triglyceride, lipocalin 2 and multiple inflammatory biomarkers and negatively associated with low-density-lipoprotein cholesterol levels. Circulating YKL-40 level is also significantly associated with the risk of PAD (p = 3.3 x 10-23). Circulating YKL40 level, but not CHI3L1 gene promoter variants, is associated with the risk of PAD in Taiwanese. The association of YKL-40 levels with multiple quantitative traits relating to the risk of PAD may provide a molecular basis linking YKL-40 to atherosclerotic cardiovascular disease. 
25486056	12	18	YKL-40	Gene	1116
25486056	34	40	CHI3L1	Gene	1116
25486056	75	90	atherosclerosis	Disease	MESH:D050197
25486056	135	160	peripheral artery disease	Disease	MESH:D058729
25486056	162	168	YKL-40	Gene	1116
25486056	252	290	atherosclerotic cardiovascular disease	Disease	MESH:D050197
25486056	382	388	YKL-40	Gene	1116
25486056	421	427	CHI3L1	Gene	1116
25486056	484	509	peripheral artery disease	Disease	MESH:D058729
25486056	511	514	PAD	Disease	MESH:D058729
25486056	524	530	YKL-40	Gene	1116
25486056	617	633	systemic disease	Disease	MESH:D034721
25486056	656	662	CHI3L1	Gene	1116
25486056	736	739	PAD	Disease	MESH:D058729
25486056	740	748	patients	Species	9606
25486056	829	835	CHI3L1	Gene	1116
25486056	861	867	YKL-40	Gene	1116
25486056	941	950	rs4950928	SNP	tmVar:rs4950928;VariantGroup:0;CorrespondingGene:1116;RS#:4950928;CorrespondingSpecies:9606
25486056	1013	1016	PAD	Disease	MESH:D058729
25486056	1017	1025	patients	Species	9606
25486056	1076	1082	YKL-40	Gene	1116
25486056	1098	1104	CHI3L1	Gene	1116
25486056	1192	1204	triglyceride	Chemical	MESH:D014280
25486056	1206	1217	lipocalin 2	Gene	3934
25486056	1231	1243	inflammatory	Disease	MESH:D007249
25486056	1342	1348	YKL-40	Gene	1116
25486056	1405	1408	PAD	Disease	MESH:D058729
25486056	1440	1445	YKL40	Gene	1116
25486056	1461	1467	CHI3L1	Gene	1116
25486056	1523	1526	PAD	Disease	MESH:D058729
25486056	1560	1566	YKL-40	Gene	1116
25486056	1632	1635	PAD	Disease	MESH:D058729
25486056	1674	1680	YKL-40	Gene	1116
25486056	1684	1722	atherosclerotic cardiovascular disease	Disease	MESH:D050197
25486056	Association	MESH:D050197	1116
25486056	Positive_Correlation	MESH:D058729	RS#:4950928;CorrespondingGene:1116
25486056	Association	MESH:D058729	1116
25486056	Association	MESH:D007249	1116
25486056	Association	MESH:D014280	1116
25486056	Association	MESH:D058729	1116

